Robert Busch
- Immunology top 1%
- T-cell and B-cell Immunology 36
- Immune Cell Function and Interaction 29
- Immunotherapy and Immune Responses 25
- Gastroenterology top 1%
- Agronomy and Crop Science top 1%
- Crop Yield and Soil Fertility 20
- Plant Science top 2%
- Wheat and Barley Genetics and Pathology 52
- Genetics and Plant Breeding 37
-
- Chronic Lymphocytic Leukemia Research 11
-
- Lymphoma Diagnosis and Treatment 10
Robert Busch
211 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 165
- Immunology 2.1k
- Gastroenterology 331
- Agronomy and Crop Science 456
- Plant Science 1.4k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Robert Busch
This map shows the geographic impact of Robert Busch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Busch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Busch more than expected).
Fields of papers citing papers by Robert Busch
This network shows the impact of papers produced by Robert Busch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Busch. The network helps show where Robert Busch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Busch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 1 | |
| 4 | 2019 | 52 | |
| 5 | Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome | 2015 | 12 |
| 6 | 2011 | 206 | |
| 7 | 2010 | 34 | |
| 8 | 2007 | 9 | |
| 9 | Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG) | 2005 | 18 |
| 10 | 2004 | 201 | |
| 11 | 2004 | 23 | |
| 12 | T-PLL-1 protocol of the German CLL study group (GCLLSG) - a prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation as first-line treatment in T-PLL. | 2003 | 6 |
| 13 | 2003 | 25 | |
| 14 | 2002 | 55 | |
| 15 | 1998 | 114 | |
| 16 | 1997 | 16 | |
| 17 | 1996 | 80 | |
| 18 | On the history of cystic fibrosis. | 1990 | 26 |
| 19 | OLAF...A Short-Strawed, High Yielding Hard Red Spring Wheat Variety | 1973 | 1 |
| 20 | 1971 | 3 |
About Robert Busch
Robert Busch is a scholar working on Immunology, Structural Biology, Agronomy and Crop Science, Plant Science and Genetics, having authored 217 papers that have together received 7.0k indexed citations. Recurring topics across this work include Wheat and Barley Genetics and Pathology (52 papers), Genetics and Plant Breeding (37 papers), T-cell and B-cell Immunology (36 papers), Immune Cell Function and Interaction (29 papers), Immunotherapy and Immune Responses (25 papers), Crop Yield and Soil Fertility (20 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Immunology (2.1k citations), Gastroenterology (331 citations), Agronomy and Crop Science (456 citations), Plant Science (1.4k citations) and Pulmonary and Respiratory Medicine (1.2k citations). Robert Busch has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Elizabeth Mellins, Jonathan B. Rothbard, J. D. Roder, H. J. Stein, K. Böttcher, Marc K. Hellerstein, Mohamad Awada, U. Fink, Robert C. Doebele and Achal Pashine. Their work appears in journals such as Crop Science, The Journal of Immunology, Environmental Research, Journal of Immunological Methods and Microscopy and Microanalysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.